Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Yates

Showing results (191-200 of 221) with videos related to

Pageof 23
Sort By:
Obstetrics & Gynecology Science|July 22, 2020
Fertility-sparing treatment in early endometrial cancer: current state and future strategiesAndreas Obermair, Eva Baxter, Donal J Brennan, et al.
Cancer Prevention Research (Philadelphia, Pa.)|May 3, 2018
Prospective Randomized Biomarker Study of Metformin and Lifestyle Intervention for Prevention in Obese Women at Increased Risk for Endometrial CancerMelinda S Yates, Adriana M Coletta, Qian Zhang, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 30, 2017
Quality assessment of delineation and dose planning of early breast cancer patients included in the randomized Skagen Trial 1Giulio Francolini, Mette S Thomsen, Esben S Yates, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 14, 2021
Novel polymer-based system for intrauterine delivery of everolimus for anti-cancer applicationsBrenda Melendez, Sarita Shah, Yunyun Jiang, et al.
Molecular Cancer Therapeutics|October 1, 2013
Another surprise from Metformin: novel mechanism of action via K-Ras influences endometrial cancer response to therapyDavid A Iglesias, Melinda S Yates, Dharini van der Hoeven, et al.
American Journal of Obstetrics and Gynecology|August 25, 2020
Endometrial biomarkers in premenopausal women with obesity: an at-risk cohortJoseph A Dottino, Qian Zhang, David S Loose, et al.
Infancy : the Official Journal of the International Society on Infant Studies|January 31, 2026
Functional Magnetic Resonance Imaging in Awake Infants: Insights From More Than 750 Scanning SessionsLillian Behm, Tristan S Yates, Juliana E Trach, et al.
Biorxiv : the Preprint Server for Biology|March 10, 2025
Data retention in awake infant fMRI: Lessons from more than 750 scanning sessionsLillian Behm, Tristan S Yates, Juliana E Trach, et al.
Molecular Cancer Therapeutics|January 24, 2007
Pharmacodynamic characterization of chemopreventive triterpenoids as exceptionally potent inducers of Nrf2-regulated genesMelinda S Yates, Masafumi Tauchi, Fumiki Katsuoka, et al.
Carcinogenesis|April 24, 2009
Genetic versus chemoprotective activation of Nrf2 signaling: overlapping yet distinct gene expression profiles between Keap1 knockout and triterpenoid-treated miceMelinda S Yates, Quynh T Tran, Patrick M Dolan, et al.
Pageof 23

Showing results (191-200 of 221) with videos related to

Sort By:
Pageof 23
Obstetrics & Gynecology Science|July 22, 2020
Fertility-sparing treatment in early endometrial cancer: current state and future strategiesAndreas Obermair, Eva Baxter, Donal J Brennan, et al.
Cancer Prevention Research (Philadelphia, Pa.)|May 3, 2018
Prospective Randomized Biomarker Study of Metformin and Lifestyle Intervention for Prevention in Obese Women at Increased Risk for Endometrial CancerMelinda S Yates, Adriana M Coletta, Qian Zhang, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 30, 2017
Quality assessment of delineation and dose planning of early breast cancer patients included in the randomized Skagen Trial 1Giulio Francolini, Mette S Thomsen, Esben S Yates, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 14, 2021
Novel polymer-based system for intrauterine delivery of everolimus for anti-cancer applicationsBrenda Melendez, Sarita Shah, Yunyun Jiang, et al.
Molecular Cancer Therapeutics|October 1, 2013
Another surprise from Metformin: novel mechanism of action via K-Ras influences endometrial cancer response to therapyDavid A Iglesias, Melinda S Yates, Dharini van der Hoeven, et al.
American Journal of Obstetrics and Gynecology|August 25, 2020
Endometrial biomarkers in premenopausal women with obesity: an at-risk cohortJoseph A Dottino, Qian Zhang, David S Loose, et al.
Infancy : the Official Journal of the International Society on Infant Studies|January 31, 2026
Functional Magnetic Resonance Imaging in Awake Infants: Insights From More Than 750 Scanning SessionsLillian Behm, Tristan S Yates, Juliana E Trach, et al.
Biorxiv : the Preprint Server for Biology|March 10, 2025
Data retention in awake infant fMRI: Lessons from more than 750 scanning sessionsLillian Behm, Tristan S Yates, Juliana E Trach, et al.
Molecular Cancer Therapeutics|January 24, 2007
Pharmacodynamic characterization of chemopreventive triterpenoids as exceptionally potent inducers of Nrf2-regulated genesMelinda S Yates, Masafumi Tauchi, Fumiki Katsuoka, et al.
Carcinogenesis|April 24, 2009
Genetic versus chemoprotective activation of Nrf2 signaling: overlapping yet distinct gene expression profiles between Keap1 knockout and triterpenoid-treated miceMelinda S Yates, Quynh T Tran, Patrick M Dolan, et al.
Pageof 23